Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

CONSENSUS HEALTH CHIEF EXECUTIVE OFFICER MICHAEL LOVETT NAMED 2024 EXECUTIVE OF THE YEAR-FOR PROFIT CATEGORY BY NJBIZ IN BUSINESS OF THE YEAR AWARDS

Consensus Health

Consensus Health, a leading New Jersey-based healthcare organization with a physician-led medical group and an Independent Physician Alliance (IPA), announced today Chief Executive Officer Michael Lovett was named a 2024 Business of the Year—Executive of the Year (For-Profit category) honoree by NJBIZ. Annually, NJBIZ Business of the Year Awards recognize the state’s most dynamic companies and leaders who share a commitment to professional excellence, business growth and their communities. This year, more than 50 organizations and only three individuals will be honored for their significant contributions to helping the state’s business community grow and prosper. "This recognition reflects Mike’s exceptional focus on leading with integrity, fostering local impact, and elevating the patient experience. His approach resonates with our mission to build a collaborative environment where both patients and providers thrive. Mike’s leadership is a key asset to our value-based care journey, and we’re honored to celebrate this achievement with him,” shared Dr. Nedal Shami, chief executive officer of CareAbout Health, a value-based care managed services organization supporting Consensus Health. Lovett commented on the acknowledgement from NJBIZ: “This honor is a tribute to Consensus Health’s 700+ team of professionals who – each and every day – positively impact healthcare across New Jersey. It is their dedication and unrelenting care for our patients’ health and wellness that allows Consensus Health to stand out. “I want to extend my deepest gratitude to our team for their contributions, our leadership for their confidence in me and the judges who took note of our impact on elevating patient care statewide. It’s truly a privilege to accept this prestigious accolade on behalf of our entire growing enterprise,” Lovett concluded. The awards will be bestowed in a ceremony hosted by NJBIZ on Thursday, December 12, 2024 to be held at The DoubleTree by Hilton Somerset. About CareAbout Health CareAbout Health provides management, resources, value-add services, technology, and other support to its portfolio of medical groups and healthcare focused companies. CareAbout Health is helping align incentives to create a world where patients, providers, and payers work together in a seamless, coordinated manner toward common goals: higher quality, lower costs, better outcomes, and healthier communities. For more information, please visit www.careabout.com. About Consensus Health Marlton, New Jersey-based Consensus Health is a leading physician-owned and -governed medical group comprised of New Jersey-based independent primary care providers and specialty doctors. Consensus Health affords its 169 member physicians across 56 practices and 69 locations clinical autonomy, which enables them to focus on the delivery of high levels of patient care within the local markets they each serve. Currently, Consensus Health provides medical care statewide throughout 18 New Jersey counties. For more information, visit www.consensushealth.com or connect with the Company on LinkedIn. Contact Details PAIRELATIONS, LLC Susan J. Turkell +1 303-766-4343 sturkell@pairelations.com Company Website https://www.consensushealth.com/

October 30, 2024 08:00 AM Eastern Daylight Time

Avenue Z Launches New Public Affairs Practice to Help Clients Navigate Complexities of Modern Advocacy

Avenue Z

Avenue Z, a media and technology company, today announced the launch of its Public Affairs Group, a multidisciplinary, strategic practice designed to shape client outcomes in public and private advocacy, shareholder activism and ESG, philanthropy and civil society, and regulatory environments. In response to the growing power and control from big media companies and tech companies, Avenue Z’s new Public Affairs Group leverages a blend of communications, media, creative, and technology to affect meaningful change. The company’s approach supports clients to achieve consensus and desired outcomes by connecting highly targeted content to the right audiences at the right time, building trust. “The way the public is gaining information and forming perspectives has changed, and organizations need to engage their audiences across all channels in new ways,” said Nneka Etoniru, Avenue Z’s EVP of Global Brand Strategy and lead of the new Public Affairs Group. “Our solutions are uniquely positioned to help clients achieve lasting influence by guiding them through critical moments, enhancing their public image, and accomplishing their goals.” “Making a quantifiable impact in public affairs, akin to brand marketing or reputation management, requires both human and technology-informed approach,” said Jeffrey Herzog, Avenue Z founder and CEO. “Our strength lies in blending storytelling, media, and data to create influential connections across channels - from the Wall Street Journal to TikTok." Avenue Z’s Public Affairs practice is tailored to serve a diverse range of clients, including: Private Sector: Helping corporations gain consensus among decision-makers and standard bearers, secure contracts and public-private partnerships, and win necessary approval. Public Sector: Assisting municipal, state, and federal agencies with raising awareness, launching public health initiatives, combatting electoral misinformation, and developing educational campaigns across demographics. High-Profile Public Figures: Assisting in navigating public opinion, counter-influencing harassment campaigns, managing crises, and curating strategically engaging online conversations to protect their reputation. Charities and Philanthropies: Supporting non-profits in raising funds, advancing agendas, enhancing prestige, and navigating challenges to maximize organizational impact. Trade Organizations and Industry Groups: Helping industry-specific organizations advocate for their members' interests, inform external audiences on policy impact, and shape public perception of their industry. Along with the practice launch, Avenue Z has released an insightful trends report, offering a deep dive into the latest shifts shaping public policy and communication, helping organizations stay ahead of the curve. Public Affairs Trend Report 2024: Shaping Perception and Driving Outcomes in High-Stakes Environments covers trends impacting key sectors from healthcare to fintech, venture capital, emerging tech, manufacturing, and more. Read the full report, here. Avenue Z’s ability to lead high-stakes special situations is built on a foundation of expertise lasting more than 25 years. The company’s heritage dates back to 1998, when digital visionary and entrepreneur Jeffrey Herzog pioneered search engine marketing and later, sold iCrossing, his first digital media company, to Hearst Magazines for $450 million. Avenue Z is a media and technology company breaking traditional boundaries between marketing, advertising and PR to increase client revenue and elevate their reputation. From the Wall Street Journal to TikTok, PR to social and search, we create narratives that drive commerce, connections, and conversion, across all channels. With experts, tech and teams based in New York, Orlando, Miami and global reach - we drive influence. Visit www.avenuez.com Contact Details Avenue Z Rachael Zahn +1 407-637-2833 press@avenuez.com Company Website https://www.avenuez.com/

October 30, 2024 07:48 AM Eastern Daylight Time

News Release

NuggMD is Providing Free Medical Cannabis Evaluations to Veterans on Veterans Day

NuggMD

NuggMD, the nation's leading telemedicine platform for cannabis, today announced that it is providing free online medical marijuana evaluations to veterans from Nov. 7 to Nov. 11. Rates of PTSD range from 10% to 30% among war-time vets and 31% struggle with chronic pain. Additionally, according to the U.S. Department of Veterans Affairs, fewer than 50% of veterans in need of mental health treatment end up receiving it. While cannabis remains illegal federally, 38 states and several U.S. territories have legalized cannabis used to treat qualifying medical conditions, among them PTSD and chronic pain. “Every adult deserves the freedom to use cannabis. That is what we stand for,” said Bobby Brock, vice president of marketing at NuggMD. “We urge our peers in the cannabis industry to use their resources to help veterans, because serving in the armed forces is one of the most selfless, patriotic things an American can do. We also invite policymakers to take seriously the potential that cannabis may have to improve the quality of life of those who choose to enlist, both as they serve and after they return home.” The free evaluations will be offered to all veterans who reside in the 28 markets that NuggMD serves, and who provide valid proof of service and their state-issued identification. The applicable states are listed on NuggMD’s website, and veterans can secure their appointment using NuggMD’s on-demand platform from 8 AM to 10 PM in their local time zone. In addition to providing free evaluations to veterans, the company is also offering a 25% discount to the spouses of veterans, under the same conditions. Since its launch in 2016, NuggMD's affiliated medical cannabis practitioners have helped over two million patients connect with qualified medical cannabis doctors. About NuggMD NuggMD is the nation's leading medical marijuana technology platform, serving patients in Arizona, California, Connecticut, Delaware, Florida, Georgia, Illinois, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, Texas, Vermont, Virginia, Washington, and West Virginia. They've connected over 2,000,000 patients face-to-face with their new medical marijuana doctors via their state-of-the-art telemedicine platform. They believe every human being has the right to explore the benefits of medical cannabis and are fully committed to helping each patient explore every option in their journey to wellness. For further information, visit https://www.nuggmd.com. Contact Details Andrew Graham +1 646-385-0189 andrew.g@getnugg.com Company Website http://www.nuggmd.com

October 29, 2024 02:50 PM Eastern Daylight Time

Study Shows PayMedix Lowers Costs and Improves Access to Healthcare for All Members

PayMedix

Today PayMedix announced findings from a longitudinal analysis of member data that shows its zero-interest financing and healthcare payments solution successfully stems the rise in health insurance costs for its employer members by as much as 40% versus the national average. Further, its data revealed that subscribers are less likely to require in-patient hospital care and access care at similar rates across all credit score categories. The findings, part of a review of 2023 data from more than 45,000 active members over a 12-month period, is the most comprehensive analysis of the long-term benefits of PayMedix’s innovative payments solution, first introduced more than 10 years ago. Highlights from the study include: Medical trend beats national benchmarks – according to Milliman’s 2023 study, the one-year and two-year annualized medical trend nationally were 6.4% and 5.4% respectively, in contrast to trend of just 4.0% (one-year) and 3.1% (two-year) for PayMedix member employers What it means: PayMedix member rates are rising at an annual rate that is approximately 40% lower than the national average. Employers who use PayMedix are saving money for themselves and their employees Equitable access to care regardless of credit scores – the PayMedix analysis showed that in 2023, employee members with low credit scores (between 350 – 649) averaged the same number of annual claims as employee members with higher credit scores (between 650 – 850+) What it means: Employers who provide members access to zero-interest financing and flexible payment plans offered through PayMedix allow all employees to access care that fits their means and budgets Lower inpatient utilization – on average, 22% of all insurance claims represent hospital inpatient care, according to Milliman’s 2023 benchmark, but only 14% of PayMedix members’ claims were for in-patient care during the same period * What it means: Lower inpatient utilization keeps costs down for everyone and illustrates how PayMedix contributes to better outcomes. In addition, when looking at claims involving professional care (e.g., visits to primary care, etc.), PayMedix outpaces national benchmarks by 10%, with 48% of all claims vs. 38% nationally. This suggests employees are going to the doctor and avoiding the need for emergent care. * “Our data demonstrates what we have believed all along – together with employers and providers, PayMedix can break the cycle of out-of-control healthcare costs and fix our broken healthcare system by providing guaranteed zero-interest financing for employees and prompt full payments to providers,” said Tom Policelli, CEO, PayMedix. “We’ve shown that over time, PayMedix not only reduces costs, but improves equitable access to the healthcare system. Nearly 25% of PayMedix members would not qualify for commercial credit. We have proven that we can drive down cost for everyone when people can access care when they need it and not when they think they can afford it.” PayMedix provides complete, uncapped financing for all in-network allowed charges that any employee may owe to providers. All employees are automatically enrolled, and PayMedix pays all participating providers in full. The employees each get a simplified consolidated statement (a SuperEOB) each month and can arrange to pay it on terms that fit their budgets. Participating providers, in turn, are simply paid the full employee balance due automatically and therefore have no consumer bill to collect. “Our solution has allowed better access to healthcare for tens of thousands of employee subscribers by making it simpler, more affordable and more equitable,” said Brian Marsella, president of PayMedix. “Add to that the satisfaction and retention of our members, with a NPS score that is three times the industry average and we’re excited about the continued potential for PayMedix.” * Reference: 2023 Milliman Medical Index (MMI) Study. Percentage noted excludes pharmacy claims. About PayMedix PayMedix, which began as the financing arm of Wisconsin-based HPS over a decade ago, is the only company solving the problem of high out-of-pocket costs for everyone – providers, patients, employers, and TPAs. PayMedix is changing how people access, use, and pay for healthcare by guaranteeing payments to providers and financing for all patients. PayMedix has processed more than $5 billion in medical payments for hospital systems and physician practices and can be implemented with any benefit plan that is using any PPO or HMO network. Contact Details PayMedix Kaitlynn Cooney +1 609-351-5944 kcooney@brodeur.com Company Website https://paymedix.com

October 29, 2024 10:00 AM Eastern Daylight Time

Greg Olsen's Youth Inc. Expands with New Podcast Season and Upcoming Commerce Platform

Youth Inc.

Youth Inc., the first digital media network dedicated exclusively to youth sports content and commerce, today announced that Season Two of its popular Youth Inc. Podcast will launch on Wednesday, Oct. 30. Following the company’s 2024 $4.5 million seed funding round, led by Will Ventures, Youth Inc. is developing a new centralized hub blending news, original content, and retail for the youth sports market. Launched in 2022, Season One of the Youth Inc. Podcast featured conversations with iconic athletes like Jerry Rice, Russell Wilson, Jennie Finch, and Dale Earnhardt Jr. After a breakout debut season with more than 400,000 downloads, millions of impressions, and a nearly perfect viewership rating, Youth Inc. Is expanding its vision as it prepares to launch Season Two. Co-founded by Emmy Award-winning NFL analyst and Pro Bowl tight end Greg Olsen, former Fanatics executive Ryan Baise and Audacy, Inc.’s Tim Murphy, the podcast will feature acclaimed sports psychologist Dr. Michael Gervais as co-host, offering crucial insights for navigating today’s complex youth sports landscape. “While there are more than 30 million young athletes in our country today, there has never been a platform designed to speak directly to families, coaches, and players about the challenges of today’s current state of play,” said Olsen. “Season one taught us invaluable lessons, and we're excited to bring even more insights and depth in Season Two. Partnering with Dr. Gervais, we’ll provide our audience with the tools and knowledge to succeed, all while making the journey engaging and enjoyable." Season Two of the podcast will address the critical challenges young athletes face today including fostering resilience, managing the pressures of competition, and leveraging mindset training for long-term success. The six-episode season is presented by two Founding Partners: Players Health, a sports technology company offering digital risk management services and insurance products to ensure a secure environment for athletes, and MaxU, a cutting-edge platform providing personalized, 24/7 support to help young athletes build skills that enhance their mental performance and overall development. As Youth Inc. enhances its content offerings, it is also set to launch a robust commerce platform in early 2025, designed to further support young athletes and their families. Led by former Fanatics head of new ventures, Ryan Baise, the platform will offer a range of products and services tailored specifically for youth sports families and coaches. "The youth sports landscape is ripe for transformation, and we believe our platform will revolutionize how families access vital information and resources," said Baise. "Our aim is to create a comprehensive marketplace where parents, athletes, and coaches can discover rigorously vetted content and products that reflect the investment they make in their young athletes' futures." To listen to Season One of the Youth Inc. podcast (available on major podcast platforms, YouTube, and social media in both video and audio formats), watch the Season Two trailer or for more information, please visit Youth Inc. Youth Inc. is the first digital media network dedicated exclusively to youth sports content and commerce. Co-founded by NFL alum and Fox Sports broadcaster Greg Olsen, former Fanatics executive, Ryan Baise, and former Audacy and New York Times Co. executive, Tim Murphy, Youth Inc. provides parents, coaches, and athletes with expert-driven guidance and resources to navigate the evolving youth sports landscape. For more information, visit www.youth.inc or follow along on YouTube, Instagram, X, and TikTok. Contact Details Youth Inc. Jackson Gaskins jgaskins@hotpaperlantern.com

October 28, 2024 09:00 AM Eastern Daylight Time

AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Alberto Santagostino to Chief Executive Officer and President of AGC Biologics, effective November 1 st. Alberto has had a distinguished career in biotech, pharma and managing large-scale global CDMO operations. His expertise and knowledge will lead AGC Biologics’ next chapter as the company reemphasizes delivering reliable services to biopharmaceutical developers without unnecessary complications. AGC Biologics will have a friendly business approach with customers and provide them with expert CDMO services to become an increasingly preferred service provider. AGC Biologics intends to be valued as collaborative, reliable and stable: it will be a safe harbor for those customers seeking to minimize geopolitical risks, intellectual property concerns, steep price expectations and transactional or confrontational supplier relationships. This direction builds on the company’s 30 years of biopharma CDMO experience, including serving more than 250 customers across over 400 different projects, with more than 90 successful regulatory inspections and 25 commercial products launched. Alberto joins AGC Biologics after most recently serving as the Head of Cell and Gene Technology (CGT) at Lonza for six years. While there, his business unit grew four-fold in size by enabling clients to advance four new CGT therapies to commercial production and many more to late-stage clinical milestones, with now thousands of patients being cured annually. During his tenure, Alberto led the industrialization of CGT therapeutics manufacturing: from a “science workshop” into “industrial scale compliant operations” with several positive Pre-Approval Inspections (PAI) from the U.S. FDA and EMA that led to three CGT biomanufacturing sites becoming licensed for commercial supply. Before Lonza, Alberto was a Partner in the Pharmaceutical & Medical Product practice at McKinsey & Co., serving more than 70 clients with over 200 projects. While there, Alberto developed a proprietary operational benchmark that analyzed the performance of more than 30 biomanufacturing sites and published books and articles about Biopharma operations. Alberto currently serves as a board member for the Alliance for Regenerative Medicine (ARM) and holds a degree in Industrial Biotechnology from the University of Milano-Bicocca and a Master of Business Administration from Politecnico di Milano. “I am excited to announce Alberto is joining us to lead AGC Biologics and to set the tone for the coming years. We share the common vision of service, delivery and quality that is at the core of AGC Group’s business philosophy,” said Murano Tadashi, President of AGC Life Science Company. “I am confident Alberto will bring both a wide knowledge of the biopharma industry and the experience of successfully leading growth at scale. He will enhance AGC Biologics’ reputation as an increasingly preferable CDMO in the industry.” “I am grateful for the opportunity to serve AGC Biologics and its team members and customers. We will have customers at the heart of our action and our technical talent as the enabler of our CDMO’s aspiration of friendly & expert services to the biopharma industry,” said Alberto Santagostino, new Chief Executive Officer at AGC Biologics. “Over the last several years our industry has faced more complexity. Chemistry Manufacturing Control (CMC), technical development and manufacturing have been a headache for the biopharma industry, also, and sometimes especially, when dealing with CDMOs. AGC Biologics aspires to become an easy choice. We will be a friendly CDMO to work with, expert and reliable in our technical role. We will leverage our technical talent, established centers of excellence, commercial track record, growing capacity at our global sites and the solidity of the parent company, to offer reliability while staying uncomplicated to work with. Ultimately, ‘#YourfriendlyCDMOexpert.’ ” For more information on AGC Biologics’ end-to-end global CDMO services in the U.S., Europe and Japan visit www.agcbio.com. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, to provide friendly and expert services. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 Team Members worldwide. AGC Biologics is a part of AGC Inc.’s Life Science Business. The Life Science Business runs 10+ facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com. Contact Details AGC Biologics Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

October 28, 2024 06:03 AM Eastern Daylight Time

AmeriLife Named to Inc.’s Power Partner Awards for the Second Year in a Row

AmeriLife

In acknowledgment of consistent excellence, Inc. Business Media has once again recognized AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions, in its third annual Power Partner Awards, which honor business-to-business (B2B) organizations across the globe that have a proven track record of supporting entrepreneurs and helping startups grow. AmeriLife claimed top honors in the Insurance and Financial Services categories, propelled by glowing endorsements from its Health and Wealth Distribution organizations. The company joined an elite group of nearly 400 global B2B organizations, all celebrated for their exceptional support to entrepreneurs and partner institutions in critical areas such as hiring, compliance, and infrastructure development. Through AmeriLife’s partnership program, company founders and leaders can shift focus and resources toward their core business objectives. “Being recognized by Inc. as a Power Partner in the health and life insurance distribution industry is a tremendous honor for AmeriLife,” said Scotty Elliott, Chief Distribution Officer of Health for AmeriLife. “This award is a powerful testament to our dedication to excellence, innovation, and providing unparalleled value to our affiliate partners. We're honored to be recognized as a trusted ally in helping companies flourish and achieve their goals in today's competitive landscape.” "This accolade is a true reflection of our steadfast dedication to superior performance, forward-thinking strategies, and providing unmatched service through our wealth distribution platform,” said Mike Vietri, Chief Distribution Officer of Wealth for AmeriLife. “We're thrilled to be distinguished for our work in financial services and our role in helping businesses and individuals prosper." Targeted expansion aligned with a holistic strategy Since 2020, AmeriLife has welcomed nearly 90 affiliates to its family of companies, culminating in establishing distinct Health and Wealth Distribution channels in January 2023. This restructuring and ongoing investments in world-class resources enable a comprehensive approach to retirement planning. Notable additions include the proprietary leads platform, LeadStar, the insights platform, Atlas, and strategic expansion within the Wealth space to include RIA and Broker-Dealer capabilities. These initiatives work together to fulfill life and health insurance needs and the premier financial services and retirement planning solutions to deliver a truly holistic approach. To view the complete list, go to: https://www.inc.com/power-partner-awards/2024. The November 2024 Issue of Inc. magazine is available online at https://www.inc.com/magazine and will be on newsstands beginning October 29, 2024. “This is our definitive listing of vendors and suppliers who have demonstrated excellence in serving small- and midsize customers,” says Inc. editor-in-chief Mike Hofman. “As part of the vetting process, our team of editors, researchers, and reporters gathered information on companies’ products and services, assessed their reputation as captured in online comments and forums, and collected customer testimonials to ensure that the sales pitch matches the client experience. In every case, we spoke to founders like you who were happy to attest to a vendor’s genuine commitment to a mutually beneficial business partnership. We’re happy to be the conduit for that positive word of mouth.” About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For over 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers through a distribution network of over 300,000 insurance agents, financial professionals, and over 160 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com and follow AmeriLife on Facebook and LinkedIn. About Inc. Inc. is the leading media brand and playbook for entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of our community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating our future. Inc.'s award-winning work achieves a monthly brand footprint of over 40 million across various channels, including events, digital, print, video, podcasts, newsletters, and social media. Its proprietary Inc. 5000 list, produced yearly since its launch as the Inc. 100 in 1982, analyzes company data to rank the fastest-growing privately held businesses in the United States. The recognition that comes with inclusion on this and other prestigious Inc. lists, such as Female Founders and Power Partners, allows the founders of top businesses to engage with an exclusive community of their peers and credibility that helps them drive sales and recruit talent. For more information, visit www.inc.com. Contact Details Jeff Maldonado media@amerilife.com Company Website https://amerilife.com/

October 24, 2024 09:00 AM Eastern Daylight Time

PathAI Unveils New Features on AISight Image Management System: Introducing Guided Algorithm Review and Z-Stack Image Support

PathAI

PathAI, a global leader in AI-powered digital pathology, today announced the launch of two new features on its AISight® 1 Image Management System (IMS): Guided Algorithm Review and Z-Stack Image Support. These enhancements reflect PathAI’s ongoing commitment to empowering pathologists with innovative tools that enhance pathology interpretation, optimize laboratory operations, and lay the foundation for broader adoption of AI tools in the field of pathology. The Guided Algorithm Review feature is designed to help pathologists streamline and enhance case evaluations by highlighting potential Fields of Interest (FOIs) identified by algorithms. TumorDetect 2, PathAI’s AI product, will be the first to incorporate this functionality, highlighting key areas of interest. By automatically pinpointing these critical areas, the feature allows pathologists to focus their initial review on the regions that require the most attention. Key Features of the Guided Algorithm Review: Gallery of FOIs: A visual gallery of algorithm-detected fields of interest provides an intuitive way for pathologists to navigate to key tissue areas requiring further analysis. Click-Through Review: Enables systematic, step-by-step navigation through regions highlighted by the AI’s predictions, such as areas with high tumor concentration or biomarker quantification, potentially streamlining the review process and enhancing thoroughness. Enhanced Interpretability: Overlays and side-by-side comparisons improve the clarity of AI predictions, allowing pathologists to better interpret and verify the results. Third-Party AI Integration: Allows for seamless integration with third-party AI algorithms, enabling pathologists to work with various AI solutions in a unified platform, enhancing flexibility and adaptability across different AI tools and workflows. In addition to the Guided Algorithm Review, PathAI’s Z-Stack Image Support introduces a multi-layer imaging capability that enables pathologists to examine all layers of a multi-layered Whole Slide Image (WSI), producing a 3D-like representation of slides. This feature is particularly beneficial in cytology, where three-dimensional cell clusters often require a more nuanced, layered analysis. Key Benefits of the Z-Stack Image Support: Multi-Layer Viewing: Pathologists can view all layers of a multi-layered Whole Slide Image (WSI), providing an experience similar to a microscope fine focus, particularly useful for cytology cases. Efficient Navigation: Features such as Focus Control and keyboard shortcuts allow for smooth transitions between image layers. Customizable Workflow: Pathologists can personalize their review process with adjustable zoom, pan, and annotation features, and track their progress through visual indicators. PathAI has also upgraded its ArtifactDetect 3 algorithm, broadening its support for additional file types, such as.mrxs format files and stains, including Masson’s Trichrome and other special stains. These improvements allow laboratories to apply quality control measures across a wider range of specimens and staining protocols, further optimizing laboratory efficiency. Additional AISight Enhancements: Refreshed User Interface: Includes categorized tables for clearer quantitative results, such as tissue areas and cell counts, facilitating easier interpretation. Custom Slide Panning: Enhanced control features like Snap to Zoom and adjustable animation durations for more precise slide navigation. Automatic Specimen Orientation: Automatically rotates skin specimens based on metadata, ensuring consistency and accuracy in evaluations. “We are thrilled to introduce these new capabilities to the AISight IMS platform,” said Eric Walk, M.D., FCAP, chief medical officer at PathAI. “The Guided Algorithm Review and Z-Stack Image Support are significant advancements that help pathologists conduct high-quality assessments with efficiency and precision. These tools help enhance and streamline case management supporting the needs of modern pathology labs.” Footnotes AISight is for research use only in the US and is not for use in diagnostic procedures. TumorDetect is a workflow optimization algorithm available on AISight for research use only. ArtifactDetect is a quality control algorithm available on AISight for research use only. About PathAI PathAI is a global leader in AI-powered digital pathology solutions, dedicated to advancing diagnostic accuracy and operational efficiency in pathology laboratories worldwide. Through the integration of cutting-edge technology and strategic partnerships, PathAI empowers pathologists to be leaders in precision pathology and shape the future of medical diagnostics. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

October 23, 2024 10:00 AM Eastern Daylight Time

Forum Health Launches Transformative Health Programs for Thyroid, Hormone, and Weight Management, Cementing Its Footprint in Michigan

Forum Health

Forum Health, LLC, a leader in personalized medicine, is excited to announce the launch of its new Integrative Health Programs in five Michigan locations. The programs feature Advanced Thyroid Care, Bioidentical Hormone Replacement Therapy for men and women, and a competitively priced Medical Weight Loss Program. Learn more about Forum Health Michigan’s Integrative Health Programs. Bruce Hamby, PA-C: "Our comprehensive Integrative Health Programs aim to transform lives by tackling the root causes of health issues. We deliver personalized care that fosters long-term health optimization, providing affordable and effective solutions for individuals seeking to enhance their health and well-being." Led by Bruce Hamby, PA-C, Taylor Consiglio, PA-C, and Holly Alderman PA-C, the new programs combine cutting-edge diagnostics not normally offered in conventional medicine with tailored treatments to help individuals resolve thyroid dysfunction, hormone imbalance, and the challenges of weight management. Forum Health’s Integrative Health Programs Include: Medical Weight Loss with Competitive Pricing - Weight loss solutions featuring GLP-1 and GIP injections focused on delivering sustainable results starting as low as $50 per week. This affordable plan offers expert care for those struggling with metabolic imbalances, stubborn weight gain, or individuals seeking a tailored approach to effective weight management. Advanced Thyroid Care: Comprehensive testing and personalized treatment to optimize thyroid function for those with hypothyroidism, hyperthyroidism, and autoimmune thyroid conditions, combining nutrition, lifestyle modifications, and targeted therapies. Bioidentical Hormone Replacement Therapy: Restores balance and vitality for men and women using bioidentical hormones that closely mimic the body's natural hormones. This customized therapy targets patient's unique needs, effectively relieving symptoms of hormone deficiency and menopause like fatigue, weight gain, and low libido. Phil Hagerman, Forum Health CEO: “Our expansion in Michigan underscores Forum Health's commitment to providing accessible, personalized care that addresses the underlying causes of health concerns. By offering advanced solutions for thyroid and hormone health, and weight management, we’re empowering individuals to take charge of their health and achieve sustainable, long-term wellness.” About Forum Health, LLC Forum Health, LLC is a nationwide provider of personalized healthcare steeped in the powerful principles of functional and integrative medicine. Our providers take a root-cause approach to care exploring lifestyle, environment, and genetics to help each patient achieve their ultimate health goals. Members have access to advanced medical treatments and technology, with care plans informed by data analytics and collaborative relationships. For more, visit www.forumhealth.com. Contact Details Forum Health Britt Wittelsberger +1 410-852-0738 bwittelsberger@forumhealth.com Company Website https://forumhealth.com

October 22, 2024 08:50 AM Eastern Daylight Time

1 2 3 4 5 ... 308